Grantham, Mayo, Van Otterloo & Co (GMO)’s Navigant Consulting, Inc. NCI Stock Holding History
Bought
Maintained
Sold
Other funds holding NCI
ECM
SM
Grantham, Mayo, Van Otterloo & Co (GMO)'s NCI Position: Q4 2017 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Navigant Consulting, Inc. (NCI) in Q4 2017, closing a stake of 67,912 shares — an estimated $1.15M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NCI in Q1 2014 and held it in 7 quarters. The position peaked at $2.64M in Q1 2017. 161 funds tracked by Wall St. Rank hold NCI as of Q4 2017.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Navigant Consulting, Inc. position as of Q4 2017 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 67,912 Navigant Consulting, Inc. shares in Q4 2017, an estimated $1.15M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Navigant Consulting, Inc. in Q1 2014 and held it in 7 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Navigant Consulting, Inc. position peaked at $2.64M in Q1 2017.
- 161 funds tracked by Wall St. Rank held Navigant Consulting, Inc. as of Q4 2017.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2017, filed 14 Feb 2018.